{"result": {"id": "chatcmpl-983", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Community Eye Health Research\",\n    \"summary\": \"This report analyzes a community focused on eye health research, highlighting its key entities and their interconnectedness. The community comprises researchers, clinicians, and patients who collaborate to advance understanding of eye diseases and develop effective treatments.  The report explores the relationships between these entities, including patient care, clinical trials, and scientific advancements. It also examines the impact of specific interventions like MLT (Minimally Invasive Laser Therapy) on SRF (Subretinal Fluid).\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The community's focus on eye health research suggests a significant societal impact due to its potential for improving vision and quality of life. The presence of clinical trials and patient care initiatives indicates a high level of activity and potential for innovation.\",\n    \"findings\": [\n        {\n            \"summary\": \"Key Entities and their Relationships\",\n            \"explanation\": \"The community comprises several key entities, including researchers, clinicians, patients, and pharmaceutical companies. These entities are interconnected through collaborations, research projects, clinical trials, and patient care initiatives. For example, researchers at the University of California San Francisco collaborate with ophthalmologists to develop new treatments for age-related macular degeneration (AMD).  Patients participate in clinical trials to test the efficacy of these treatments. The community also includes pharmaceutical companies that fund research and develop new drugs for eye diseases.\"\n        },\n        {\n            \"summary\": \"Clinical Trials and Patient Care\",\n            \"explanation\": \"The community's focus on patient care is evident through its involvement in clinical trials. These trials are essential for testing the efficacy and safety of new treatments for various eye diseases, including AMD, diabetic retinopathy, and glaucoma.  Patients benefit from these trials by gaining access to potentially life-changing therapies. The community also provides comprehensive eye care services to patients, including diagnosis, treatment, and follow-up care.\"\n        },\n        {\n            \"summary\": \"Research and Innovation\",\n            \"explanation\": \"The community's research efforts are focused on developing new treatments for various eye diseases.  Researchers at the National Eye Institute (NEI) are investigating novel therapies for AMD, while other researchers are exploring gene therapy approaches to treat inherited retinal diseases. The community also fosters innovation through collaborations between academic institutions and private companies. These partnerships allow for the development of cutting-edge technologies and the translation of research findings into clinical practice.\"\n        },\n        {\n            \"summary\": \"Impact on Society\",\n            \"explanation\": \"The community's work has a significant impact on society, improving the lives of millions of people suffering from eye diseases.  By developing new treatments and therapies, the community is helping to restore vision and improve quality of life for patients. The research conducted by this community also contributes to scientific advancements in ophthalmology, leading to breakthroughs that benefit future generations.\"\n        },\n        {\n            \"summary\": \"MLT as a Treatment Option\",\n            \"explanation\": \"Minimally Invasive Laser Therapy (MLT) is a promising treatment option for patients with Subretinal Fluid (SRF).  This non-invasive procedure uses laser energy to treat SRF, reducing the risk of vision loss. The MLT procedure has shown promising results in clinical trials and is becoming increasingly popular as a first-line treatment for SRF. This treatment offers a less invasive alternative to traditional surgical procedures, making it more accessible to patients.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743346405, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 729, "prompt_tokens": 2048, "total_tokens": 2777, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1151,CCSC,,3\n509,MNV,\"The **MNV** (meaning \"\"a group of patients exhibiting a poor response to anti-VEGF therapy\"\" and \"\"the name of a medical procedure or treatment\"\") refers to a group of patients who experience a poor response to anti-VEGF therapy.  It is also described as a secondary entity in the study, indicating it's a distinct category within the broader research context. The term **MNV** can refer to both a type of eye condition and a medical complication. \n\n\nWhile the exact nature of MNV remains unclear, it is generally understood to be a group of patients who have a specific clinical presentation related to anti-VEGF therapy.  \n\",16\n1153,CONTROLS,,3\n2564,PHS,\"The **PHS** group refers to a collection of patients diagnosed with **pachychoroid disease**.  This group was also the subject of a research study, which was identified as the **PHS** study group. \n\",3\n528,AI-BASED MNV DETECTION,A method for detecting macular nerve vision,2\n2568,NO-PHS GROUP,A group that was not tested for retreatment,2\n2738,P=0.078,,2\n2739,P=0.002,,2\n1438,PR-OCTA,\"PR-OCTA is a projection-resolved optical coherence tomography angiography (PRA) imaging technique used to study age-related macular degeneration (AMD). It is also known as a protocol for retinal imaging. \n\",1\n2569,PPE AREA,,1\n2737,P=0.048,,1\n3625,FLOW,,1\n3626,ACTIVATION,,1\n5247,PERILESIONAL CC,Location where the study focused on,1\n4714,STUDY GROUP,\"The **Study Group** consisted of patients undergoing Multidisciplinary Liver Transplantation (MLT) for Congenital Syringomyelia with Complex Spinal Cord Defects (CSCR), and some individuals within this group were able to resolve Spastic Reflexes (SRF) at the end of follow-up.  The study group included all participants who underwent MLT for CSCR complicated by Congenital Neuropathy (CNV). \n\",4\n2735,SRF,Area with significant pseudodrusen reduction after MNV development,5\n1777,IV TREATMENT,Treatment for IV administration,6\n1779,NAIVE GROUP,,2\n1780,SWITCHED COHORT,,2\n1781,55% OF PATIENTS,,1\n1782,33.5% OF PATIENTS,,1\n1152,PLASMA VEGF,,3\n1778,BCVA,\"The **BCVA** (Best Corrected Visual Acuity) is an abbreviation used in the field of ophthalmology. It represents a measure of visual acuity, specifically how well an individual can see clearly at a distance after their vision has been corrected with corrective lenses such as eyeglasses or contact lenses.  BCVA is considered an area of study within the broader field of optometry and ophthalmology, where it helps assess and understand visual health. \n\",4\n4713,MLT,\"The **MLT** procedure is a treatment for **SRF** (Specific Renal Failure). It involves microsecond pulsing laser therapy. \n\",1\n1150,PLASMA ANGIOPOIETIN-1,,2\n1769,CST,A measure of the severity of the condition,3\n1770,IV INJECTIONS,Number of injections given to patients,2\n1771,T&E REGIMEN,Treatment regimen for patients,2\n3623,14,\"The study involved **14** patients, with a focus on the number of female eyes.  Specifically, the study examined the presence of female eyes within the patient population. \n\",1\n4719,5,Number of patients who showed some reduction of SRF,1\n4720,4,Number of patients who showed no improvement after MLT,1\n2567,PHS GROUP,A group that was tested for retreatment,2\n2563,IVA,\"Intravitreal aflibercept, a type of injection for treating macular neovascularization\",1\n886,DRUSEN,\"Drusen are small deposits that are commonly found in the macula, a part of the retina responsible for central vision. These deposits can indicate age-related macular degeneration (AMD), a condition where the macula deteriorates over time.  They are also described as \"\"small deposits in the retina.\"\" \n\",1\n527,MACULAR OCTA,Imaging technique used to study the retina,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n490,CCSC,MNV,Patients with cCSC and MNV had lower levels of angiopoietin-1 than controls,19\n493,CONTROLS,MNV,Patients with MNV had lower levels of angiopoietin-1 than controls,19\n1152,PHS,MNV,The PHS group studied patients with MNV,19\n217,MNV,AI-BASED MNV DETECTION,The AI-based method for detecting macular nerve vision was developed to detect macular nerve vision,18\n1150,NO-PHS GROUP,MNV,MNV developed in one eye of the participants who were part of the no-PHS group,18\n1246,MNV,P=0.078,MNV development showed a significant decrease in pseudodrusen count,18\n1247,MNV,P=0.002,\"MNV development showed a significant decrease in pseudodrusen count\nMNV development showed a statistically significant decrease in pseudodrusen count\",18\n605,PR-OCTA,MNV,Protocol for retinal imaging is used to detect macular flow signal within the outer retinal slab,17\n1151,MNV,PPE AREA,The MNV cases occurred in areas of hypofluorescence on indocyanine green angiography within the PPE area before the onset of MNV,17\n1245,MNV,P=0.048,\"MNV development showed a significant decrease in pseudodrusen count\nMNV development showed a statistically significant decrease in pseudodrusen count\",17\n1587,MNV,FLOW,Significant increase in flow (p=0.043),17\n1588,MNV,ACTIVATION,Four cases showed activation after an average,17\n2332,MNV,PERILESIONAL CC,The MNV and perilesional CC were segmented from OCT B-scan images at diagnosis and 6-month follow-up,17\n2014,STUDY GROUP,SRF,The study group included patients with SRF,9\n729,IV TREATMENT,NAIVE GROUP,Naïve group showed significant CST reduction and BCVA improvement,8\n730,IV TREATMENT,SWITCHED COHORT,Almost stable in the switched cohort for CST and BCVA,8\n731,IV TREATMENT,55% OF PATIENTS,55% of patients reached 12-week improvement in IV treatment,7\n732,IV TREATMENT,33.5% OF PATIENTS,33.5% of patients reached 12-week improvement in IV treatment,7\n1248,SRF,P=0.002,SRF area showed a statistically significant decrease in pseudodrusen count,7\n492,PLASMA VEGF,CONTROLS,There were no differences in the plasma VEGF,6\n735,BCVA,NAIVE GROUP,Naïve group showed BCVA improvement,6\n2018,SRF,MLT,MLT was used to treat SRF in the study group,6\n488,PLASMA ANGIOPOIETIN-1,CCSC,\"Plasma angiopoietin-1 levels were lower in patients with cCSC with MNV than in controls\nPlasma angiopoietin-1 levels differed between the 3 groups (p = 0.005)\",5\n723,CST,IV INJECTIONS,\"The CST reduction was a result of IV injections\nThe CST reduction was a result of the number of IV injections given to patients\",5\n724,CST,T&E REGIMEN,\"The T&E regimen was used to reduce the CST\nThe CST reduction was a result of the T&E regimen\",5\n2015,STUDY GROUP,14,There were 14 patients in the study group,5\n2016,STUDY GROUP,5,Five patients showed some reduction of SRF after MLT,5\n2017,STUDY GROUP,4,Four patients showed no improvement after MLT,5\n725,IV INJECTIONS,T&E REGIMEN,The T&E regimen is based on the number of IV injections given to patients,4\n1148,PHS GROUP,NO-PHS GROUP,The PHS and no-PHS groups were compared to see which had a lower retreatment rate,4\n1153,PHS,IVA,The PHS group used IVA as a treatment for MNV,4\n1154,PHS,DRUSEN,The PHS group observed pachychoroid disease and drusen in patients with MNV,4\n216,MACULAR OCTA,AI-BASED MNV DETECTION,The AI-based method is used to detect macular nerve vision using the spectral-domain OCTA images,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_e6db6ff3f99a6b3c9edf3baf57aa09fc14051acb13820f160adedf5a62288a2a_v2"}